ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phelan-McDermid Syndrome (PMS) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8K14136
Home | Market Reports | Health| Reproductive Health
Global Phelan McDermid Syndrome PMS Market Research Report 2023
BUY CHAPTERS

Global Phelan-McDermid Syndrome (PMS) Market Research Report 2025

Code: QYRE-Auto-8K14136
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CellCentric
Epigentek
Sonic Genetics
AMO Pharma
Neuren Pharmaceuticals Limited
Celgen
Oryzon Genomics SA
Astex Pharmaceutucals
Mendelian

Phelan-McDermid Syndrome (PMS) Market

The global market for Phelan-McDermid Syndrome (PMS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Phelan-McDermid syndrome (PMS) is a rare genetic condition that causes developmental and speech delays, behavioral problems and a weakened or no ability to feel pain or sweat. Phelan-McDermid syndrome is a congenital condition (condition that is present at birth) that can affect people of all genders.
Phelan-McDermid Syndrome (PMS) is a rare genetic disorder caused by the deletion or mutation of the terminal end of chromosome 22. It is characterized by developmental delays, intellectual disabilities, and various physical and neurological abnormalities.
Market Overview: The market for Phelan-McDermid Syndrome is relatively small due to the rarity of the condition. It primarily focuses on providing diagnostic tests, therapeutic interventions, and supportive care for patients with PMS.
Diagnostic Tests: The market includes companies that offer genetic testing and diagnostic services to identify chromosomal abnormalities associated with Phelan-McDermid Syndrome. These tests help in confirming the diagnosis of PMS and identifying specific genetic variations.
Therapeutic Interventions: Currently, there is no specific cure for Phelan-McDermid Syndrome. However, research and clinical trials are ongoing to develop targeted therapies that can alleviate the symptoms and improve the quality of life for individuals with PMS. The market may involve pharmaceutical companies working on potential treatments or therapies targeting specific pathways affected by PMS.
Supportive Care: The market may also include companies providing supportive care products and services for individuals with Phelan-McDermid Syndrome. This may include therapeutic interventions, assistive devices, and rehabilitation services aimed at managing symptoms, promoting development, and improving the overall well-being of patients with PMS.
This report aims to provide a comprehensive presentation of the global market for Phelan-McDermid Syndrome (PMS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phelan-McDermid Syndrome (PMS).
The Phelan-McDermid Syndrome (PMS) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phelan-McDermid Syndrome (PMS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phelan-McDermid Syndrome (PMS) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Phelan-McDermid Syndrome (PMS) Market Report

Report Metric Details
Report Name Phelan-McDermid Syndrome (PMS) Market
Segment by Type
  • Applied Behavior Analysis
  • Occupational Therapy
  • Physical Therapy
  • Others
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellcentric, Celgen, EpiGentek, Oryzon Genomics SA, Astex Pharmaceutucals, Sonic Genetics, Mendelian, AMO Pharma, Neuren Pharmaceuticals Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Phelan-McDermid Syndrome (PMS) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Phelan-McDermid Syndrome (PMS) Market report?

Ans: The main players in the Phelan-McDermid Syndrome (PMS) Market are Cellcentric, Celgen, EpiGentek, Oryzon Genomics SA, Astex Pharmaceutucals, Sonic Genetics, Mendelian, AMO Pharma, Neuren Pharmaceuticals Limited

What are the Application segmentation covered in the Phelan-McDermid Syndrome (PMS) Market report?

Ans: The Applications covered in the Phelan-McDermid Syndrome (PMS) Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Phelan-McDermid Syndrome (PMS) Market report?

Ans: The Types covered in the Phelan-McDermid Syndrome (PMS) Market report are Applied Behavior Analysis, Occupational Therapy, Physical Therapy, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Applied Behavior Analysis
1.2.3 Occupational Therapy
1.2.4 Physical Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Phelan-McDermid Syndrome (PMS) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phelan-McDermid Syndrome (PMS) Market Perspective (2020-2031)
2.2 Global Phelan-McDermid Syndrome (PMS) Growth Trends by Region
2.2.1 Global Phelan-McDermid Syndrome (PMS) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Phelan-McDermid Syndrome (PMS) Historic Market Size by Region (2020-2025)
2.2.3 Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Region (2026-2031)
2.3 Phelan-McDermid Syndrome (PMS) Market Dynamics
2.3.1 Phelan-McDermid Syndrome (PMS) Industry Trends
2.3.2 Phelan-McDermid Syndrome (PMS) Market Drivers
2.3.3 Phelan-McDermid Syndrome (PMS) Market Challenges
2.3.4 Phelan-McDermid Syndrome (PMS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phelan-McDermid Syndrome (PMS) Players by Revenue
3.1.1 Global Top Phelan-McDermid Syndrome (PMS) Players by Revenue (2020-2025)
3.1.2 Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Players (2020-2025)
3.2 Global Phelan-McDermid Syndrome (PMS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Phelan-McDermid Syndrome (PMS) Revenue
3.4 Global Phelan-McDermid Syndrome (PMS) Market Concentration Ratio
3.4.1 Global Phelan-McDermid Syndrome (PMS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phelan-McDermid Syndrome (PMS) Revenue in 2024
3.5 Global Key Players of Phelan-McDermid Syndrome (PMS) Head office and Area Served
3.6 Global Key Players of Phelan-McDermid Syndrome (PMS), Product and Application
3.7 Global Key Players of Phelan-McDermid Syndrome (PMS), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phelan-McDermid Syndrome (PMS) Breakdown Data by Type
4.1 Global Phelan-McDermid Syndrome (PMS) Historic Market Size by Type (2020-2025)
4.2 Global Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Type (2026-2031)
5 Phelan-McDermid Syndrome (PMS) Breakdown Data by Application
5.1 Global Phelan-McDermid Syndrome (PMS) Historic Market Size by Application (2020-2025)
5.2 Global Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Phelan-McDermid Syndrome (PMS) Market Size (2020-2031)
6.2 North America Phelan-McDermid Syndrome (PMS) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025)
6.4 North America Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phelan-McDermid Syndrome (PMS) Market Size (2020-2031)
7.2 Europe Phelan-McDermid Syndrome (PMS) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025)
7.4 Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size (2020-2031)
8.2 Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size by Region (2020-2025)
8.4 Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phelan-McDermid Syndrome (PMS) Market Size (2020-2031)
9.2 Latin America Phelan-McDermid Syndrome (PMS) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025)
9.4 Latin America Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size (2020-2031)
10.2 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025)
10.4 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellcentric
11.1.1 Cellcentric Company Details
11.1.2 Cellcentric Business Overview
11.1.3 Cellcentric Phelan-McDermid Syndrome (PMS) Introduction
11.1.4 Cellcentric Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.1.5 Cellcentric Recent Development
11.2 Celgen
11.2.1 Celgen Company Details
11.2.2 Celgen Business Overview
11.2.3 Celgen Phelan-McDermid Syndrome (PMS) Introduction
11.2.4 Celgen Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.2.5 Celgen Recent Development
11.3 EpiGentek
11.3.1 EpiGentek Company Details
11.3.2 EpiGentek Business Overview
11.3.3 EpiGentek Phelan-McDermid Syndrome (PMS) Introduction
11.3.4 EpiGentek Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.3.5 EpiGentek Recent Development
11.4 Oryzon Genomics SA
11.4.1 Oryzon Genomics SA Company Details
11.4.2 Oryzon Genomics SA Business Overview
11.4.3 Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Introduction
11.4.4 Oryzon Genomics SA Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.4.5 Oryzon Genomics SA Recent Development
11.5 Astex Pharmaceutucals
11.5.1 Astex Pharmaceutucals Company Details
11.5.2 Astex Pharmaceutucals Business Overview
11.5.3 Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Introduction
11.5.4 Astex Pharmaceutucals Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.5.5 Astex Pharmaceutucals Recent Development
11.6 Sonic Genetics
11.6.1 Sonic Genetics Company Details
11.6.2 Sonic Genetics Business Overview
11.6.3 Sonic Genetics Phelan-McDermid Syndrome (PMS) Introduction
11.6.4 Sonic Genetics Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.6.5 Sonic Genetics Recent Development
11.7 Mendelian
11.7.1 Mendelian Company Details
11.7.2 Mendelian Business Overview
11.7.3 Mendelian Phelan-McDermid Syndrome (PMS) Introduction
11.7.4 Mendelian Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.7.5 Mendelian Recent Development
11.8 AMO Pharma
11.8.1 AMO Pharma Company Details
11.8.2 AMO Pharma Business Overview
11.8.3 AMO Pharma Phelan-McDermid Syndrome (PMS) Introduction
11.8.4 AMO Pharma Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.8.5 AMO Pharma Recent Development
11.9 Neuren Pharmaceuticals Limited
11.9.1 Neuren Pharmaceuticals Limited Company Details
11.9.2 Neuren Pharmaceuticals Limited Business Overview
11.9.3 Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Introduction
11.9.4 Neuren Pharmaceuticals Limited Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
11.9.5 Neuren Pharmaceuticals Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
CellCentric
Epigentek
Sonic Genetics
AMO Pharma
Neuren Pharmaceuticals Limited
Celgen
Oryzon Genomics SA
Astex Pharmaceutucals
Mendelian
List of Tables
 Table 1. Global Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Applied Behavior Analysis
 Table 3. Key Players of Occupational Therapy
 Table 4. Key Players of Physical Therapy
 Table 5. Key Players of Others
 Table 6. Global Phelan-McDermid Syndrome (PMS) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Phelan-McDermid Syndrome (PMS) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Phelan-McDermid Syndrome (PMS) Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Phelan-McDermid Syndrome (PMS) Market Share by Region (2020-2025)
 Table 10. Global Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Phelan-McDermid Syndrome (PMS) Market Share by Region (2026-2031)
 Table 12. Phelan-McDermid Syndrome (PMS) Market Trends
 Table 13. Phelan-McDermid Syndrome (PMS) Market Drivers
 Table 14. Phelan-McDermid Syndrome (PMS) Market Challenges
 Table 15. Phelan-McDermid Syndrome (PMS) Market Restraints
 Table 16. Global Phelan-McDermid Syndrome (PMS) Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Phelan-McDermid Syndrome (PMS) Market Share by Players (2020-2025)
 Table 18. Global Top Phelan-McDermid Syndrome (PMS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phelan-McDermid Syndrome (PMS) as of 2024)
 Table 19. Ranking of Global Top Phelan-McDermid Syndrome (PMS) Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Phelan-McDermid Syndrome (PMS) Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Phelan-McDermid Syndrome (PMS), Headquarters and Area Served
 Table 22. Global Key Players of Phelan-McDermid Syndrome (PMS), Product and Application
 Table 23. Global Key Players of Phelan-McDermid Syndrome (PMS), Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Phelan-McDermid Syndrome (PMS) Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Type (2020-2025)
 Table 27. Global Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Type (2026-2031)
 Table 29. Global Phelan-McDermid Syndrome (PMS) Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Application (2020-2025)
 Table 31. Global Phelan-McDermid Syndrome (PMS) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Application (2026-2031)
 Table 33. North America Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Cellcentric Company Details
 Table 49. Cellcentric Business Overview
 Table 50. Cellcentric Phelan-McDermid Syndrome (PMS) Product
 Table 51. Cellcentric Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 52. Cellcentric Recent Development
 Table 53. Celgen Company Details
 Table 54. Celgen Business Overview
 Table 55. Celgen Phelan-McDermid Syndrome (PMS) Product
 Table 56. Celgen Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 57. Celgen Recent Development
 Table 58. EpiGentek Company Details
 Table 59. EpiGentek Business Overview
 Table 60. EpiGentek Phelan-McDermid Syndrome (PMS) Product
 Table 61. EpiGentek Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 62. EpiGentek Recent Development
 Table 63. Oryzon Genomics SA Company Details
 Table 64. Oryzon Genomics SA Business Overview
 Table 65. Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Product
 Table 66. Oryzon Genomics SA Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 67. Oryzon Genomics SA Recent Development
 Table 68. Astex Pharmaceutucals Company Details
 Table 69. Astex Pharmaceutucals Business Overview
 Table 70. Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Product
 Table 71. Astex Pharmaceutucals Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 72. Astex Pharmaceutucals Recent Development
 Table 73. Sonic Genetics Company Details
 Table 74. Sonic Genetics Business Overview
 Table 75. Sonic Genetics Phelan-McDermid Syndrome (PMS) Product
 Table 76. Sonic Genetics Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 77. Sonic Genetics Recent Development
 Table 78. Mendelian Company Details
 Table 79. Mendelian Business Overview
 Table 80. Mendelian Phelan-McDermid Syndrome (PMS) Product
 Table 81. Mendelian Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 82. Mendelian Recent Development
 Table 83. AMO Pharma Company Details
 Table 84. AMO Pharma Business Overview
 Table 85. AMO Pharma Phelan-McDermid Syndrome (PMS) Product
 Table 86. AMO Pharma Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 87. AMO Pharma Recent Development
 Table 88. Neuren Pharmaceuticals Limited Company Details
 Table 89. Neuren Pharmaceuticals Limited Business Overview
 Table 90. Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Product
 Table 91. Neuren Pharmaceuticals Limited Revenue in Phelan-McDermid Syndrome (PMS) Business (2020-2025) & (US$ Million)
 Table 92. Neuren Pharmaceuticals Limited Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Phelan-McDermid Syndrome (PMS) Picture
 Figure 2. Global Phelan-McDermid Syndrome (PMS) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Phelan-McDermid Syndrome (PMS) Market Share by Type: 2024 VS 2031
 Figure 4. Applied Behavior Analysis Features
 Figure 5. Occupational Therapy Features
 Figure 6. Physical Therapy Features
 Figure 7. Others Features
 Figure 8. Global Phelan-McDermid Syndrome (PMS) Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Phelan-McDermid Syndrome (PMS) Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Others Case Studies
 Figure 13. Phelan-McDermid Syndrome (PMS) Report Years Considered
 Figure 14. Global Phelan-McDermid Syndrome (PMS) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Phelan-McDermid Syndrome (PMS) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Phelan-McDermid Syndrome (PMS) Market Share by Region: 2024 VS 2031
 Figure 17. Global Phelan-McDermid Syndrome (PMS) Market Share by Players in 2024
 Figure 18. Global Top Phelan-McDermid Syndrome (PMS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phelan-McDermid Syndrome (PMS) as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Phelan-McDermid Syndrome (PMS) Revenue in 2024
 Figure 20. North America Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Phelan-McDermid Syndrome (PMS) Market Share by Country (2020-2031)
 Figure 22. United States Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Phelan-McDermid Syndrome (PMS) Market Share by Country (2020-2031)
 Figure 26. Germany Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Phelan-McDermid Syndrome (PMS) Market Share by Region (2020-2031)
 Figure 34. China Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Phelan-McDermid Syndrome (PMS) Market Share by Country (2020-2031)
 Figure 42. Mexico Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Share by Country (2020-2031)
 Figure 46. Turkey Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Phelan-McDermid Syndrome (PMS) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Cellcentric Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 50. Celgen Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 51. EpiGentek Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 52. Oryzon Genomics SA Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 53. Astex Pharmaceutucals Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 54. Sonic Genetics Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 55. Mendelian Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 56. AMO Pharma Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 57. Neuren Pharmaceuticals Limited Revenue Growth Rate in Phelan-McDermid Syndrome (PMS) Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Pre Menstrual Syndrome Market Insights Forecast to 2030
Global PMS And Menstrual Health Supplements Market Research Report 2024
Global Smith Magenis Syndrome Treatment Market Insights Forecast to 2030
Premenstrual Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Premenstrual Dysphoric Disorder PMDD Market Insights Forecast to 2030
Global Smith Lemli Opitz Syndrome Market Insights Forecast to 2030
Global Fragile X Syndrome Testing Market Research Report 2024
Polycystic Ovarian Syndrome PCOS Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pendred Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poly Myalgia Rheumatica Treatment Market Research Report 2024
Mucopolysaccharidosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mucopolysaccharidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hunter Syndrome Treatment Market Insights Forecast to 2030
POEMS Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Familial Chylomicronemia Syndrome Therapeutics Market Research Report 2025
Hunter Syndrome Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Wolfram Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stein Leventhal Syndrome Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eisenmenger Syndrome Treatment Market Research Report 2024
Muckle Wells Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions